Cargando…
Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
BACKGROUND: Liver transplantation (LT) is regarded as the best treatment for both primary and recurrent hepatocellular carcinoma (HCC). Post-transplant HCC recurrence rate is relatively low but significant, ranging from 10%-30% according to different series. When recurrence happens, it is usually ex...
Autores principales: | Ma, Ka Wing, She, Wong Hoi, Chan, Albert Chi Yan, Cheung, Tan To, Fung, James Yan Yue, Dai, Wing Chiu, Lo, Chung Mau, Chok, Kenneth Siu Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475674/ https://www.ncbi.nlm.nih.gov/pubmed/31040897 http://dx.doi.org/10.4251/wjgo.v11.i4.322 |
Ejemplares similares
-
Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels
por: She, Wong Hoi, et al.
Publicado: (2018) -
Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence
por: Au, Kin-Pan, et al.
Publicado: (2021) -
Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation
por: Au, Kin-Pan, et al.
Publicado: (2022) -
Outcomes of right-lobe and left-lobe living-donor liver transplantations using small-for-size grafts
por: She, Wong Hoi, et al.
Publicado: (2017) -
Impact of small-for-size liver grafts on medium-term and long-term graft survival in living donor liver transplantation: A meta-analysis
por: Ma, Ka Wing, et al.
Publicado: (2019)